<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> is increased in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> and its symptoms may be overlooked </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, its treatment can be complex and is not without complications </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a case of an adolescent boy who developed a cerebral sinus <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> during a relapse of his <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and who, while on treatment with <z:chebi fb="5" ids="28304">heparin</z:chebi>, developed <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> (HIT) </plain></SENT>
<SENT sid="3" pm="."><plain>The treatment was then switched to fondaparinux, a synthetic and selective inhibitor of activated factor X </plain></SENT>
</text></document>